期刊文献+

瑞芬太尼联合丙泊酚在胃镜检查中的应用 被引量:4

Study on painless gastroscopy with rimifentani and propofol
原文传递
导出
摘要 目的研究瑞芬太尼和丙泊酚联合用于胃镜检查的镇静效果和安全性。方法胃镜检查患者120例给予瑞芬太尼和丙泊酚(镇静组),对照组120例常规操作(不给任何镇静药),比较两组胃镜检查过程中患者的反应和感受,观察其清醒时间及检查前、中、后血压、心率、血氧饱和度变化。结果镇静组患者98.3%无不适,而对照组为0(P〈0.01)。镇静组咳嗽、躁动、恶心呕吐和咽喉不适的发生率分别为1.7%、3.3%、1.7%与0,明显低于对照组(9.2%、26.7%、48.3%与100%)(P〈0.01),检查中有血压下降,但检查结束后迅速恢复至检查前水平。结论胃镜检查时应用瑞芬太尼和丙泊酚静脉镇静是一种安全、有效的方法。 Objective To study the efficacy and safety of sedation in gastroscopy with a combined use of rimifentani and propofol compared to a control,non-sedative group. Methods 120 cases in sedative group were given intravenous rimifentani and propofol. Patients' feeling and discomfort,operator's satisfaction and operative duration were compared with the control group( n = 120, without sedation). The changes of blood pressure, heat rate and blood oxygen saturation were recorded and analysed. Results 118 patients(98.3 % ) in sedative group and 0 patient (0) in control group did not complain any discomfort and pain duing gastroscopy(P 〈 0.01 ). The incidence of cough, restlessness, nausea and vomiting, and guttural discomfort in sedative group ( 1.7 %, 3.3 %, 1.7 %, and 0, respectively) was lower as compared with the control group ( 9.2 %, 26.7 % , 48.3 % and 100 % , respectively, P 〈 0.01). The blood pressure in sedative group was decreased duing the procedure and recovcred after the procedure. Conclusion With intravenous use of rimifentani and propofol,gastroscopy can be performed effectively and safely.
出处 《中国基层医药》 CAS 2008年第8期1261-1262,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 瑞芬太尼 丙泊酚 胃镜检查 镇静 Rimifentani Propofol Gastroscopy Sedation
  • 相关文献

参考文献4

二级参考文献12

  • 1倪明,刘华东.芬太尼-丙泊酚用于胃镜术的镇痛[J].中国疼痛医学杂志,2004,10(3):187-187. 被引量:4
  • 2Forrest FC, Tooley MA, Saunders PR, et al. Propofol infusion and the suppression of consciousness: the EEG and dose requirements. Br J Anaesth, 1994,72: 35-41.
  • 3Smith C, McEwan AI, Jhaveri R, et al. The interaction of fentanyl on Cp50 of propofol for loss of consciousndss and skin ineision.Anesthesiology, 1994,81: 820-828.
  • 4Swinhoe CF, Peacock JE, Glen JB, et al. Evaluation of the predictive performance of a 'Diprifusor' TCI system. Anaesthesia, 1998,53(Suppl1): 61-67.
  • 5Kirkpatrick T, Cockshott ID, Douglas FJ, et al. Pharmacokinetics of propofol (Diprivan) in elderly patients. Br J Anaesth, 1988, 60: 146-150.
  • 6Scott JC, Ponganis KV, Stanski DR. EEG quantitation of narcotic effect:The comparative pharmacodynamics of fentanyl and alfentanil.Anesthesiology, 1985, 62:234-241.
  • 7Kazama T, Ikeda K, Morita K. The pharmacodynamic interaction between propofol and fentanyl with respect to the suppression of somatic or hemodynamic responses to skin incision, peritoneum incision, abdominal wall retraction. Anesthesiology, 1998, 89:894-906.
  • 8Stanley TH, Webster LR. Anesthetic requirements and cardiovascular eftects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man.Anesth Analg, 1978, 57: 411.
  • 9Foxex P. Cardiovascular effects of propofol. J Drug Dev, 1991, 4:3-49.
  • 10Mcquay HJ, Stoeckel H. Plasma fentanyl concentration and clinical observations during and after operation. Br J Anaesth, 1979, 51: 543.

共引文献56

同被引文献33

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部